InvestorLens

ZTS — ZOETIS INC

Health Care

Sign in to save6 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying ZTS?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Net accumulation · 3 buying vs 0 selling last quarter
73
Macro Tailwind
Macro conditions are mixed for this sector
53
Congressional Activity
2 congressional purchases, 1 sale disclosed in the last 6 months
Why? — Evidence & Confidence ▾

Of 3 tracked investors who changed their ZTS position last quarter, 3 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 2 congressional purchases, 1 sale disclosed in the last 6 months.

Supporting evidence
  • +3 tracked investors added or increased positions last quarter (George Soros, Steve Cohen, Ray Dalio)
  • +6 tracked investors reported holding ZTS at their latest filing
  • +2 congressional purchases disclosed in the last 6 months
Contradicting evidence — always shown
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About ZOETIS INC (ZTS)

ZOETIS INC (ZTS) appears in the most recent 13F filings of 6 tracked institutional investors. ZOETIS INC is classified in the Health Care sector. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $374M. Across recent filings, tracked investors recorded 5 new positions, 8 increased, 4 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ZTS

72
/100
Institutional Accumulation
Added / Increased13
Reduced4
Exited1
BearishBullish
Crowded Trade Score™

How many top investors track ZTS

40
/100
Moderate Interest
6investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

ZTS Ownership Composition

How ZOETIS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
93% of tracked value
Institutions
6
tracked investors
Total Reported
$565.3M
combined 13F value
Types2
  • Multi-Strategy / Quant93.0%
  • Macro7.0%
Multi-Strategy / Quant(3)
93.0%
Macro(3)
7.0%

Tracked investors currently reporting ZTS

  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    5.2M
    Value
    $374.5M
    % Portfolio
    0.04%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    2M
    Value
    $144.3M
    % Portfolio
    0.05%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    389.9K
    Value
    $28M
    % Portfolio
    0.04%
  • Ray DalioJun 30, 2026
    Bridgewater Associates
    Shares
    134.2K
    Value
    $9.6M
    % Portfolio
    0.04%
  • George SorosJun 30, 2026
    Soros Fund Management
    Shares
    27.8K
    Value
    $2M
    % Portfolio
    0.02%
  • Steve CohenJun 30, 2026
    Point72 Asset Management
    Shares
    95.3K
    Value
    $6.8M
    % Portfolio
    0.01%

Recent activity

Frequently asked questions

How many institutional investors hold ZTS?
6 tracked institutional investors disclosed a position in ZTS (ZOETIS INC) in their most recent 13F filing.
Who is the largest institutional holder of ZTS?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in ZTS, valued at $374M.
Did institutional ownership of ZTS increase or decrease?
Across recent 13F filings, tracked investors recorded 5 new positions, 8 increased, 4 reduced, and 1 fully exited ZTS.
What sector is ZTS in?
ZOETIS INC is classified in the Health Care GICS sector.
Where does this ZTS ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
ZTS (ZOETIS INC) — Institutional Holders & 13F History — InvestorLens